Notably, PD-1 NVs, Tim-3 NVs, and PD-1/Tim-3 NVs increased the proportion of CD8+ T cells within the tumor microenvironment, with the hybrid nanovesicles producing the most significant enhancement (Figure 5A, Supplementary Figure S4). The gene discussed is CD8A; the disease is neoplasm.